Cannabinoids: Glutamatergic Transmission and Kynurenines.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Advances in neurobiology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1007/978-3-319-28383-8_10PMID 27651254
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neurobiological Interactions Between Stress and the Endocannabinoid System

  2016cited by this paper
• The Genetic Link between Parkinson's Disease and the Kynurenine Pathway Is Still Missing

  2015cited by this paper
• Tryptophan-Degrading Enzymes in Tumoral Immune Resistance

  2015cited by this paper
• Tryptophan-Degrading Enzymes in Tumoral Immune Resistance

  2015cited by this paper
• Increased tonic cannabinoid CB1R activity and brain region-specific desensitization of CB1R Gi/o signaling axis in mice with global genetic knockout of monoacylglycerol lipase.

  2015cited by this paper
• Cannabinoid agonists rearrange synaptic vesicles at excitatory synapses and depress motoneuron activity in vivo.

  2015cited by this paper
• Cannabinoid CB1 Receptor Calibrates Excitatory Synaptic Balance in the Mouse Hippocampus

  2015cited by this paper
• Brain structural and clinical changes after first episode psychosis: Focus on cannabinoid receptor 1 polymorphisms.

  2015cited by this paper
• Activation of the kynurenine pathway and increased production of the excitotoxin quinolinic acid following traumatic brain injury in humans

  2015cited by this paper
• Cannabinoid receptor agonists reduce the short-term mitochondrial dysfunction and oxidative stress linked to excitotoxicity in the rat brain.

  2015cited by this paper
• Endocannabinoids drive the acquisition of an alternative phenotype in microglia.

  2015cited by this paper
• Effects of the endogenous cannabinoid anandamide on voltage‐dependent sodium and calcium channels in rat ventricular myocytes

  2014cited by this paper
• The Endocannabinoid Anandamide Inhibits Voltage-Gated Sodium Channels Nav1.2, Nav1.6, Nav1.7, and Nav1.8 in Xenopus Oocytes

  2014cited by this paper
• Quinolinic acid toxicity on oligodendroglial cells: relevance for multiple sclerosis and therapeutic strategies

  2014cited by this paper
• Kynurenines with Neuroactive and Redox Properties: Relevance to Aging and Brain Diseases

  2014cited by this paper
• The cannabinoid receptor 1 associates with NMDA receptors to produce glutamatergic hypofunction: implications in psychosis and schizophrenia

  2014cited by this paper
• A restricted population of CB1 cannabinoid receptors with neuroprotective activity

  2014cited by this paper
• Distinct modulation of the endocannabinoid system upon kainic acid-induced in vivo seizures and in vitro epileptiform bursting.

  2014cited by this paper
• Inhibitors of quinolinic acid synthesis: new weapons in the study of neuroinflammatory diseases.

  2014cited by this paper
• The role of cannabinoid 1 receptor expressing interneurons in behavior.

  2014cited by this paper
• "Hotheaded": the role OF TRPV1 in brain functions.

  2014cited by this paper
• Toward the Development of Bivalent Ligand Probes of Cannabinoid CB1 and Orexin OX1 Receptor Heterodimers.

  2014cited by this paper
• Tryptophan-Catabolizing Enzymes – Party of Three

  2014cited by this paper
• The kynurenine pathway is involved in bacterial meningitis

  2014cited by this paper
• Therapeutic potential of cannabinoid medicines.

  2014cited by this paper
• A systemically-available kynurenine aminotransferase II (KAT II) inhibitor restores nicotine-evoked glutamatergic activity in the cortex of rats.

  2014cited by this paper
• TRPV1 in the central nervous system: synaptic plasticity, function, and pharmacological implications.

  2014cited by this paper
• CB1 and GPR55 receptors are co-expressed and form heteromers in rat and monkey striatum.

  2014cited by this paper
• Involvement of the Kynurenine Pathway in Human Glioma Pathophysiology

  2014cited by this paper
• IDO2 in Immunomodulation and Autoimmune Disease

  2014cited by this paper
• Imbalanced Kynurenine Pathway in Schizophrenia

  2014cited by this paper
• Prenatal inhibition of the kynurenine pathway leads to structural changes in the hippocampus of adult rat offspring

  2014cited by this paper
• The Kynurenine Pathway in Stem Cell Biology

  2013cited by this paper
• GPR55, a G-Protein Coupled Receptor for Lysophosphatidylinositol, Plays a Role in Motor Coordination

  2013cited by this paper
• Quinolinic Acid: An Endogenous Neurotoxin with Multiple Targets

  2013cited by this paper
• Cannabinoid Receptors Couple to NMDA Receptors to Reduce the Production of NO and the Mobilization of Zinc Induced by Glutamate

  2013cited by this paper
• Reduced cannabinoid CB1 receptor binding in alcohol dependence measured with positron emission tomography

  2013cited by this paper
• Delineation of Domains Within the Cannabinoid CB1 and Dopamine D2 Receptors That Mediate the Formation of the Heterodimer Complex

  2013cited by this paper
• Targeting the Intracellular Environment in Cystic Fibrosis: Restoring Autophagy as a Novel Strategy to Circumvent the CFTR Defect

  2013cited by this paper
• GPR55 and GPR35 and their relationship to cannabinoid and lysophospholipid receptors.

  2013cited by this paper
• HINT1 protein cooperates with cannabinoid 1 receptor to negatively regulate glutamate NMDA receptor activity

  2013cited by this paper
• Screening genetic variability at the CNR1 gene in both major depression etiology and clinical response to citalopram treatment

  2013cited by this paper
• Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid

  2013cited by this paper
• Cortical glutamic acid decarboxylase 67 deficiency results in lower cannabinoid 1 receptor messenger RNA expression: implications for schizophrenia.

  2012cited by this paper
• Presynaptic CB(1) cannabinoid receptors control frontocortical serotonin and glutamate release--species differences.

  2012cited by this paper
• Quinolinic Acid, an Endogenous Molecule Combining Excitotoxicity, Oxidative Stress and Other Toxic Mechanisms

  2012cited by this paper
• Kynurenines in the mammalian brain: when physiology meets pathology

  2012cited by this paper
• CNS effects of CB2 cannabinoid receptors: beyond neuro-immuno-cannabinoid activity

  2012cited by this paper
• Associations between Cannabinoid Receptor-1 (CNR1) Variation and Hippocampus and Amygdala Volumes in Heavy Cannabis Users

  2012cited by this paper
• MAPK14 and CNR1 gene variant interactions: effects on brain volume deficits in schizophrenia patients with marijuana misuse

  2012cited by this paper
• Kynurenines in the CNS: recent advances and new questions

  2012cited by this paper
• Potential protective effects of cannabidiol on neuroanatomical alterations in cannabis users and psychosis: a critical review.

  2012cited by this paper
• Cannabinoids: novel medicines for the treatment of Huntington's disease.

  2012cited by this paper
• Impact of genetic variability in nicotinic acetylcholine receptors on nicotine addiction and smoking cessation treatment.

  2011cited by this paper
• Activation of Orexin 1 Receptors in the Periaqueductal Gray of Male Rats Leads to Antinociception via Retrograde Endocannabinoid (2-Arachidonoylglycerol)-Induced Disinhibition

  2011cited by this paper
• The interplay between indoleamine 2,3-dioxygenase 1 (IDO1) and cyclooxygenase (COX)-2 in chronic inflammation and cancer.

  2011cited by this paper
• The Highs and Lows of Cannabinoid Receptor Expression in Disease: Mechanisms and Their Therapeutic Implications

  2011cited by this paper
• Association study of Cannabinoid receptor 1 (CNR1) gene in tardive dyskinesia

  2011cited by this paper
• Two opposite effects of Δ9‐tetrahydrocannabinol on subthalamic nucleus neuron activity: Involvement of GABAergic and glutamatergic neurotransmission

  2010cited by this paper
• Cerebrospinal fluid levels of the endocannabinoid anandamide are reduced in patients with untreated newly diagnosed temporal lobe epilepsy

  2010cited by this paper
• Endocannabinoids and cannabinoid analogues block cardiac hKv1.5 channels in a cannabinoid receptor-independent manner.

  2010cited by this paper
• The effects of anandamide transport inhibitor AM404 on voltage-dependent calcium channels.

  2010cited by this paper
• Molecular Basis for a High-Potency Open-Channel Block of Kv1.5 Channel by the Endocannabinoid Anandamide

  2010cited by this paper
• Ligand- and Heterodimer-Directed Signaling of the CB1 Cannabinoid Receptor

  2010cited by this paper
• Retrograde Endocannabinoid Signaling Reduces GABAergic Synaptic Transmission to Gonadotropin-Releasing Hormone Neurons

  2010cited by this paper
• Type 1 cannabinoid receptor mapping with [18F]MK-9470 PET in the rat brain after quinolinic acid lesion: a comparison to dopamine receptors and glucose metabolism

  2010cited by this paper
• A Common CNR1 (Cannabinoid Receptor 1) Haplotype Attenuates the Decrease in HDL Cholesterol That Typically Accompanies Weight Gain

  2010cited by this paper
• Investigation of CNR1 and FAAH endocannabinoid gene polymorphisms in bipolar disorder and major depression.

  2010cited by this paper
• Effects of Kynurenine Pathway Metabolites on Intracellular NAD+ Synthesis and Cell Death in Human Primary Astrocytes and Neurons

  2009cited by this paper
• Endocannabinoid-mediated control of synaptic transmission.

  2009cited by this paper
• Delta9-tetrahydrocannabinol and cannabidiol modulate mitogen-induced tryptophan degradation and neopterin formation in peripheral blood mononuclear cells in vitro.

  2009cited by this paper
• Enzymatic formation of anandamide.

  2009cited by this paper
• Therapeutic time window of cannabidiol treatment on delayed ischemic damage via high-mobility group box1-inhibiting mechanism.

  2009cited by this paper
• Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity.

  2009cited by this paper
• Cannabinoid receptors in brain: pharmacogenetics, neuropharmacology, neurotoxicology, and potential therapeutic applications.

  2009cited by this paper
• Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophrenia.

  2008cited by this paper
• Multiple pathways involved in the biosynthesis of anandamide.

  2008cited by this paper
• Possible glutamatergic and lipid signalling mechanisms in ECT-induced retrograde amnesia: experimental evidence for involvement of COX-2, and review of literature.

  2008cited by this paper
• Endocannabinoid signaling in the spinal locomotor circuitry.

  2008cited by this paper
• Pretreatment with subeffective doses of Rimonabant attenuates orexigenic actions of orexin A-hypocretin 1.

  2008cited by this paper
• Endocannabinoid receptor 1 gene variations increase risk for obesity and modulate body mass index in European populations.

  2008cited by this paper
• Involvement of subthalamic nucleus in the stimulatory effect of Delta(9)-tetrahydrocannabinol on dopaminergic neurons.

  2008cited by this paper
• EXPRESSION OF BRAIN DERIVED NEUROTROPHIC ACTOR AND TYPE-1 CANNABINOID RECEPTOR AFTER STRIATAL

  2008cited by this paper
• Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum

  2008cited by this paper
• Endogenous cannabinoid anandamide inhibits nicotinic acetylcholine receptor function in mouse thalamic synaptosomes

  2008cited by this paper
• Rosmarinic acid inhibits indoleamine 2,3-dioxygenase expression in murine dendritic cells.

  2007cited by this paper
• Association Between Single Nucleotide Polymorphisms in the Cannabinoid Receptor Gene (CNR1) and Impulsivity in Southwest California Indians

  2007cited by this paper
• Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses.

  2007cited by this paper
• The endocannabinoid anandamide inhibits the function of alpha4beta2 nicotinic acetylcholine receptors.

  2007cited by this paper
• The Endocannabinoid Anandamide Inhibits the Function of α4β2 Nicotinic Acetylcholine Receptors

  2007cited by this paper
• The orphan receptor GPR55 is a novel cannabinoid receptor

  2007cited by this paper
• The cannabinoid receptor agonist WIN 55,212-2 attenuates the effects induced by quinolinic acid in the rat striatum.

  2006cited by this paper
• Δ9-Tetrahydrocannabinol and Endogenous Cannabinoid Anandamide Directly Potentiate the Function of Glycine Receptors

  2006cited by this paper
• Anandamide administration alone and after inhibition of fatty acid amide hydrolase (FAAH) increases dopamine levels in the nucleus accumbens shell in rats

  2006cited by this paper
• Receptor-independent actions of cannabinoids on cell membranes: focus on endocannabinoids.

  2006cited by this paper
• Neuromodulation via conditional release of endocannabinoids in the spinal locomotor network.

  2005cited by this paper
• Glycine Receptors in CNS Neurons as a Target for Nonretrograde Action of Cannabinoids

  2005cited by this paper
• Effects of saturated long-chain N-acylethanolamines on voltage-dependent Ca2+ fluxes in rabbit T-tubule membranes.

  2005cited by this paper
• Sodium channel inhibition by anandamide and synthetic cannabimimetics in brain.

  2003cited by this paper
• The Endogenous Cannabinoid Anandamide Inhibits α7 Nicotinic Acetylcholine Receptor-Mediated Responses in Xenopus Oocytes

  2003cited by this paper

• Inhibition of endocannabinoid hydrolases MAGL, FAAH and ABHD6 by AKU-005 reduces ex vivo cortical spreading depression

  2025cites this paper
• Kynurenine amplifies tetrahydrocannabinol-induced sensorimotor impairment and classic "tetrad" effects in mice.

  2025cites this paper
• Anandamide and WIN 55212–2 Afford Protection in Rat Brain Mitochondria in a Toxic Model Induced by 3-Nitropropionic Acid: an In Vitro Study

  2024cites this paper
• Biomarkers of Migraine: An Integrated Evaluation of Preclinical and Clinical Findings

  2023cites this paper
• Monoacylglycerol Lipase Inhibition Prevents Short-Term Mitochondrial Dysfunction and Oxidative Damage in Rat Brain Synaptosomal/Mitochondrial Fractions and Cortical Slices: Role of Cannabinoid Receptors

  2023cites this paper
• Inhibiting Endocannabinoid Hydrolysis as Emerging Analgesic Strategy Targeting a Spectrum of Ion Channels Implicated in Migraine Pain

  2022cites this paper
• Alterations in rat prefrontal cortex kynurenic acid levels are involved in the enduring cognitive dysfunctions induced by tetrahydrocannabinol exposure during the adolescence

  2022cites this paper
• Therapeutic Molecular Insights into the Active Engagement of Cannabinoids in the Therapy of Parkinson’s Disease: A Novel and Futuristic Approach

  2022cites this paper
• Pro-Inflammatory Cytokines: Potential Links between the Endocannabinoid System and the Kynurenine Pathway in Depression

  2021cites this paper
• Prenatal THC exposure raises kynurenic acid levels in the prefrontal cortex of adult rats.

  2020cites this paper
• Long-term systemic administration of kynurenic acid brain region specifically elevates the abundance of functional CB1 receptors in rats.

  2020cites this paper
• URB597 Prevents the Short-Term Excitotoxic Cell Damage in Rat Cortical Slices: Role of Cannabinoid 1 Receptors

  2020cites this paper
• Kynurenines and the Endocannabinoid System in Schizophrenia: Common Points and Potential Interactions

  2019cites this paper
• Role of the kynurenine pathway and the endocannabinoid system as modulators of inflammation and personality traits.

  2019cites this paper
• Dietary Directions Against Dementia Disorders

  2018cites this paper
• Interactions between the Kynurenine and the Endocannabinoid System with Special Emphasis on Migraine

  2017influential citation